These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23144775)

  • 1. Relevance of brain lesion location to cognition in relapsing multiple sclerosis.
    Rossi F; Giorgio A; Battaglini M; Stromillo ML; Portaccio E; Goretti B; Federico A; Hakiki B; Amato MP; De Stefano N
    PLoS One; 2012; 7(11):e44826. PubMed ID: 23144775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain networks disconnection in early multiple sclerosis cognitive deficits: an anatomofunctional study.
    Louapre C; Perlbarg V; García-Lorenzo D; Urbanski M; Benali H; Assouad R; Galanaud D; Freeman L; Bodini B; Papeix C; Tourbah A; Lubetzki C; Lehéricy S; Stankoff B
    Hum Brain Mapp; 2014 Sep; 35(9):4706-17. PubMed ID: 24687771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis.
    Zhao L; Ng A; Chen Q; Lam B; Abrigo J; Au C; Mok VCT; Wong A; Lau AY
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1193-1203. PubMed ID: 32519512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
    Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M
    J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain macro- and microscopic damage in patients with paediatric MS.
    Absinta M; Rocca MA; Moiola L; Ghezzi A; Milani N; Veggiotti P; Comi G; Filippi M
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1357-62. PubMed ID: 20660915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E; Hojjat SP; Vitorino R; Carroll TJ; Cantrell CG; Lee L; Taylor MW; Morrow SA; Benhabib H; Aviv RI; Kassner A
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.
    Bendfeldt K; Blumhagen JO; Egger H; Loetscher P; Denier N; Kuster P; Traud S; Mueller-Lenke N; Naegelin Y; Gass A; Hirsch J; Kappos L; Nichols TE; Radue EW; Borgwardt SJ
    Hum Brain Mapp; 2010 Oct; 31(10):1542-55. PubMed ID: 20108225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P; Pagani E; Morelli ME; Copetti M; Martinelli V; Pirro F; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
    Yu HJ; Christodoulou C; Bhise V; Greenblatt D; Patel Y; Serafin D; Maletic-Savatic M; Krupp LB; Wagshul ME
    Neuroimage; 2012 Feb; 59(4):3713-22. PubMed ID: 22062194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset.
    Altermatt A; Gaetano L; Magon S; Häring DA; Tomic D; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Brain Topogr; 2018 Sep; 31(5):886-894. PubMed ID: 29845492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.
    Zhang X; Zhang F; Huang D; Wu L; Ma L; Liu H; Zhao Y; Yu S; Shi J
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis.
    Vinciguerra C; Giorgio A; Zhang J; Nardone V; Brocci RT; Pastò L; Niccolai C; Stromillo ML; Mortilla M; Amato MP; De Stefano N
    Brain Imaging Behav; 2021 Aug; 15(4):2228-2233. PubMed ID: 33033983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions.
    Hulst HE; Steenwijk MD; Versteeg A; Pouwels PJ; Vrenken H; Uitdehaag BM; Polman CH; Geurts JJ; Barkhof F
    Neurology; 2013 Mar; 80(11):1025-32. PubMed ID: 23468546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.